Chetan Meditech Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 4.00 Cr
as on 24-10-2024
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.45 Cr
as on 24-10-2024
- Revenue 57.31%
(FY 2023)
- Profit 59.21%
(FY 2023)
- Ebitda 48.20%
(FY 2023)
- Net Worth 56.39%
(FY 2023)
- Total Assets 43.72%
(FY 2023)
About Chetan Meditech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company has closed loans amounting to ₹4.45 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajendrakumar Patel and Shweta Patel serve as directors at the Company.
- CIN/LLPIN
U29299GJ2003PTC043060
- Company No.
043060
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Oct 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Chetan Meditech Private Limited offer?
Chetan Meditech Private Limited offers a wide range of products and services, including Orthopedic Equipment & Supplies, Orthopedic Trauma Implants, Forceps & Graspers, Tissue Unifying Instruments & Materials, Orthopedic Implants, Orthopedic Surgical Instruments, Orthopedic Instruments.
Who are the key members and board of directors at Chetan Meditech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shweta Patel  | Director | 15-Oct-2003 | Current |
| Rajendrakumar Patel | Director | 15-Oct-2003 | Current |
Financial Performance of Chetan Meditech.
Chetan Meditech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.31% increase. The company also saw a substantial improvement in profitability, with a 59.21% increase in profit. The company's net worth Soared by an impressive increase of 56.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chetan Meditech?
In 2023, Chetan Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Apr 2016 | ₹3.00 Cr | Satisfied |
Small Industries Development Bank Of India Creation Date: 10 Oct 2011 | ₹1.05 Cr | Satisfied |
Central Bank Of India Creation Date: 04 Nov 2003 | ₹4.00 M | Satisfied |
How Many Employees Work at Chetan Meditech?
Chetan Meditech has a workforce of 119 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chetan Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chetan Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
